Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area Download as PDF April 05, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascula...
Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study Download as PDF March 28, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to trea...
Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life Download as PDF February 28, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser....
Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial Download as PDF February 18, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascula...
Ra Medical Systems, Inc. Announces Closing of $12.1 Million Underwritten Public Offering Download as PDF February 08, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular di...
Ra Medical Systems Granted U.S. Patent for a Support Catheter for use Supporting a Liquid Core Ablation Catheter Download as PDF February 10, 2022 CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser sys...
09/01/2020
September is Peripheral Artery Disease Awareness Month. PAD affects >17M Americans but only 20-30% seek treatment. Approximately 200,000 amputations are performed annually in the U.S. due to PAD. Learn about DABRA as a tool to treat PAD https://www.ramed.com/patients-vascular/
11/09/2019
Thank you Mohammad M. Ansari, MD and CV Ramana, MD for your great work and support during the DABRA hands-on cadaver workshops earlier this week at VIVA19.
10/31/2019
Wishing everyone a Happy Halloween.
10/22/2019
We are excited to be attending . Be sure to visit us at booth #415 or attend the Wednesday hands-on cadaver workshops to experience the unique abilities of wireless, DABRA Excimer Laser Photoablation. Or attend Tuesdays Disruptive Technology Session to hear Mohammad Ansari, MD speak on DABRA and its clinical performance.
10/02/2019
Great work performed by Drs. Choudry, Chotani, Rothstein and Rajvanshi from Washington Vascular Specialists and Washington Cardiovascular Institute in Takoma Park, MD in successfully diagnosing and treating a 61-year-old female who presented with severe common femoral artery disease and three prior, failed, femoropopliteal graft bypass procedures. Upon failure of the last bypass, the patient was told her only remaining option was amputation. The team successfully treated the common femoral artery with DABRA, followed by stenting and PTA – resuming flow through the common femoral artery and avoiding amputation. http://ow.ly/Po8h50wyU1J
09/05/2019
Be sure to catch the following poster presentation: Non-traumatic intra-luminal recanalization of difficult below-the-knee total occlusions using combination of DABRA Excimer Laser ablation and back-end-wire support in a crossing catheter by Kan Karl Zhang, MD (P-714)
Be the first to know and let us send you an email when DABRA Catheter and Laser posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Advanced Excimer Laser-Based Vascular and Dermatological Therapies
Ra Medical Systems was founded in 2002 by Dean Irwin and Melissa Burstein to design, develop, and commercialize excimer lasers for the treatment of dermatologic and cardiovascular diseases.
We are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. We believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions.
We currently manufacture and market two lines of products:
DABRA Catheter and Laser is cleared by the U.S. FDA as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, including peripheral artery disease (PAD) and critical limb ischemia (CLI).
Pharos Excimer Laser is FDA cleared as a tool used in the treatment of inflammatory skin conditions, including psoriasis, atopic dermatitis, and leukoderma.